Epidermal growth factor receptor expression in human malignant glioma: in vitro and in vivo effects of application of monoclonal antibodies to the epidermal growth factor receptor

Ähnliche Einträge

• Epidermal growth factor receptor and mammalian target of rapamycin as therapeutic targets in malignant glioma: current clinical status and perspectives
  von: Ronellenfitsch, Michael Wilfried, et al.
  Veröffentlicht: (2010)
• A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
  von: Westphal, Manfred, et al.
  Veröffentlicht: (2015)
• Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma
  von: Schlegel, Jürgen, et al.
  Veröffentlicht: (1994)
• CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation
  von: Zhao, Jing, et al.
  Veröffentlicht: (2017)
• Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours
  von: Halatsch, Marc-Eric, et al.
  Veröffentlicht: (2006)